Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04544709 · ClinicalTrials.gov registry record · Phase 4
Intradiscal Platelet Rich Plasma
A Phase 4 study, sponsored by University of Utah.
- Terminated
- Registry status
- Phase 4
- Development phase
- 3
- Enrollment target
NCT04544709: Clinical Trial Phase 4 study, sponsored by University of Utah.
NCT04544709 is a Phase 4 study that was terminated before completion, run by University of Utah. The registered enrollment target is 3 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04544709, a Phase 4 study, was terminated before completion, sponsored by University of Utah.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 3 participants
- Enrollment target
Study Summary
To assess changes in pain and function in patients with discogenic low back pain after a standard of care intradiscal injection of Platelet-Rich Plasma (PRP).
Primary Outcome
Proportion of participants with ≥80% and ≥50% reductions from baseline in 7-day average low back pain intensity scores on the Numeric Rating Scale (NRS) at the 2-month follow-up assessment.
Interventions
- DRUG Low back intradiscal injection of platelet rich plasma (PRP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2019-02-14 |
| Est. Completion | 2022-07-29 |
| Phase | Phase 4 |
Why NCT04544709 stopped before completion
NCT04544709 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Low back intradiscal injection of platelet rich plasma (PRP) is the first listed.
NCT04544709 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04544709 about?
NCT04544709 is a clinical study titled "Intradiscal Platelet Rich Plasma". To assess changes in pain and function in patients with discogenic low back pain after a standard of care intradiscal injection of Platelet-Rich Plasma (PRP).
What is the current status of trial NCT04544709?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 3 participants. The study started on 2019-02-14. Estimated completion is 2022-07-29.
What interventions are being tested in trial NCT04544709?
The interventions under investigation include: Low back intradiscal injection of platelet rich plasma (PRP) (DRUG).
Who is sponsoring clinical trial NCT04544709?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04544709's enrollment target sits among peer trials
3 1995th of 2000 higher than 3 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI